These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 18997481)
1. This issue at a glance: skin reactions of astronauts in space and microstructures of topically applied formulations. Lademann J; Fluhr J Skin Pharmacol Physiol; 2008; 21(5):245. PubMed ID: 18997481 [No Abstract] [Full Text] [Related]
2. Advanced topical formulations (ATF). Hadgraft J; Lane ME Int J Pharm; 2016 Nov; 514(1):52-57. PubMed ID: 27260130 [TBL] [Abstract][Full Text] [Related]
3. The transdermal revolution. Thomas BJ; Finnin BC Drug Discov Today; 2004 Aug; 9(16):697-703. PubMed ID: 15341783 [TBL] [Abstract][Full Text] [Related]
4. Change in skin physiological parameters in space--report on and results of the first study on man. Tronnier H; Wiebusch M; Heinrich U Skin Pharmacol Physiol; 2008; 21(5):283-92. PubMed ID: 18663342 [TBL] [Abstract][Full Text] [Related]
5. Low voltage electroporation of the skin, or is it iontophoresis? Hui SW Biophys J; 1998 Feb; 74(2 Pt 1):679-80. PubMed ID: 9533681 [No Abstract] [Full Text] [Related]
6. Interview with Richard H Guy by Hannah Coaker. Guy RH Ther Deliv; 2014 Feb; 5(2):123-8. PubMed ID: 24483191 [No Abstract] [Full Text] [Related]
7. Selective weighting of cutaneous receptor feedback and associated balance impairments following short duration space flight. Strzalkowski ND; Lowrey CR; Perry SD; Williams DR; Wood SJ; Bent LR Neurosci Lett; 2015 Apr; 592():94-8. PubMed ID: 25711797 [TBL] [Abstract][Full Text] [Related]
8. In vitro methods for screening transdermal formulations. Tsai PC; Lee S; Michniak-Kohn B Ther Deliv; 2015; 6(9):1043-52. PubMed ID: 26419344 [TBL] [Abstract][Full Text] [Related]
9. How do the pharmacokinetics of drugs change in astronauts in space? Eyal S Expert Opin Drug Metab Toxicol; 2020 May; 16(5):353-356. PubMed ID: 32223468 [No Abstract] [Full Text] [Related]
10. Role of complexes formation between drugs and penetration enhancers in transdermal delivery. Drakulić BJ; Juranić IO; Erić S; Zloh M Int J Pharm; 2008 Nov; 363(1-2):40-9. PubMed ID: 18675333 [TBL] [Abstract][Full Text] [Related]
14. Percutaneous absorption of chemicals: developing an understanding for the treatment of disease in frogs. Llewelyn VK; Berger L; Glass BD J Vet Pharmacol Ther; 2016 Apr; 39(2):109-21. PubMed ID: 26456710 [TBL] [Abstract][Full Text] [Related]
15. Subcutaneous Injection Volume of Biopharmaceuticals-Pushing the Boundaries. Mathaes R; Koulov A; Joerg S; Mahler HC J Pharm Sci; 2016 Aug; 105(8):2255-9. PubMed ID: 27378678 [TBL] [Abstract][Full Text] [Related]